森萱医药
(920946)
| 流通市值：42.72亿 | | | 总市值：42.73亿 |
| 流通股本：4.27亿 | | | 总股本：4.27亿 |
| 报告期 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 542,877,681.42 | 479,118,465.9 | 458,624,592.8 | 537,868,689.73 |
| 交易性金融资产 | 128,438,484.18 | 154,637,921.11 | 133,558,084.28 | 137,550,364.69 |
| 应收票据及应收账款 | 77,212,513.42 | 81,056,317.36 | 65,653,787.04 | 60,695,494.42 |
| 其中：应收票据 | 14,337,623.47 | 14,275,589.12 | 11,833,606.52 | 10,373,736.88 |
| 应收账款 | 62,874,889.95 | 66,780,728.24 | 53,820,180.52 | 50,321,757.54 |
| 应收款项融资 | 33,288,238.32 | 34,512,941.25 | 25,490,716.17 | 28,760,907.04 |
| 预付款项 | 3,049,196.62 | 3,712,758.77 | 5,008,135.09 | 5,707,783.24 |
| 其他应收款合计 | 167,100.27 | 127,670.97 | 169,677.78 | 184,931.66 |
| 存货 | 108,778,088.67 | 112,279,118.16 | 124,072,283.11 | 119,135,520.81 |
| 其他流动资产 | 363,875.18 | 118,508.34 | 211,929.04 | 143,263.72 |
| 流动资产合计 | 894,175,178.08 | 865,563,701.86 | 812,789,205.31 | 890,046,955.31 |
| 非流动资产: | | | | |
| 固定资产 | 296,641,206.47 | 307,534,150.11 | 317,895,384.65 | 329,161,523.78 |
| 在建工程 | 2,519,194.38 | 2,125,851.49 | 1,087,597.14 | 997,169.82 |
| 使用权资产 | 793,837.71 | 934,976.83 | 614,001.72 | 1,021,980.27 |
| 无形资产 | 34,457,835.83 | 34,747,926.22 | 35,038,016.6 | 35,328,106.99 |
| 递延所得税资产 | 5,921,703.06 | 5,802,954.43 | 5,288,553.49 | 5,351,690.22 |
| 其他非流动资产 | 209,306,109.85 | 185,705,115.37 | 184,641,394.22 | 112,786,630.14 |
| 非流动资产合计 | 549,639,887.3 | 536,850,974.45 | 544,564,947.82 | 484,647,101.22 |
| 资产总计 | 1,443,815,065.38 | 1,402,414,676.31 | 1,357,354,153.13 | 1,374,694,056.53 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 35,228,750.87 | 32,202,165.5 | 32,127,499.98 | 30,897,076.1 |
| 应付账款 | 35,228,750.87 | 32,202,165.5 | 32,127,499.98 | 30,897,076.1 |
| 合同负债 | 9,488,507.8 | 4,129,386.98 | 5,807,750.41 | 4,970,695.32 |
| 应付职工薪酬 | 27,600,539.94 | 20,506,898.93 | 16,903,276.85 | 15,548,097 |
| 应交税费 | 5,748,844.48 | 9,769,520.23 | 9,517,121.81 | 8,953,807.9 |
| 其他应付款合计 | 7,161,896.03 | 6,340,535.86 | 5,110,076.38 | 5,183,864.01 |
| 一年内到期的非流动负债 | 211,900.98 | 143,674.88 | 12,753.83 | 999,416.31 |
| 其他流动负债 | 8,362,543.91 | 8,760,832.34 | 7,578,023.41 | 5,845,037.49 |
| 流动负债合计 | 93,802,984.01 | 81,853,014.72 | 77,056,502.67 | 72,397,994.13 |
| 非流动负债: | | | | |
| 租赁负债 | 540,771.15 | 472,413.06 | - | - |
| 递延收益 | 2,107,804.23 | 2,161,810.05 | 2,215,815.87 | 2,269,821.69 |
| 递延所得税负债 | 5,683,156.51 | 3,684,657.35 | 3,233,913.11 | 3,238,250.02 |
| 非流动负债合计 | 8,331,731.89 | 6,318,880.46 | 5,449,728.98 | 5,508,071.71 |
| 负债合计 | 102,134,715.9 | 88,171,895.18 | 82,506,231.65 | 77,906,065.84 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 426,918,340 | 426,918,340 | 426,918,340 | 426,918,340 |
| 资本公积 | 218,680,457.68 | 218,259,925.93 | 217,839,394.18 | 217,559,039.68 |
| 专项储备 | 2,481,386.11 | 4,575,058.11 | 3,743,730.19 | 2,842,363.3 |
| 盈余公积 | 56,035,528.72 | 49,089,945.29 | 49,089,945.29 | 49,089,945.29 |
| 未分配利润 | 561,147,599.01 | 540,264,673.34 | 504,528,696.38 | 525,409,670.55 |
| 归属于母公司股东权益合计 | 1,265,263,311.52 | 1,239,107,942.67 | 1,202,120,106.04 | 1,221,819,358.82 |
| 少数股东权益 | 76,417,037.96 | 75,134,838.46 | 72,727,815.44 | 74,968,631.87 |
| 股东权益合计 | 1,341,680,349.48 | 1,314,242,781.13 | 1,274,847,921.48 | 1,296,787,990.69 |
| 负债和股东权益合计 | 1,443,815,065.38 | 1,402,414,676.31 | 1,357,354,153.13 | 1,374,694,056.53 |
| 公告日期 | 2026-04-22 | 2025-10-29 | 2025-08-29 | 2025-04-29 |
| 审计意见(境内) | 标准无保留意见 | | | |